Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival
帕博利珠单抗治疗难治性食管癌的II期研究及其疗效和生存率相关因素
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-002472
de Klerk, Leonie K; Patel, Anuj K; Derks, Sarah; Pectasides, Eirini; Augustin, Jeremy; Uduman, Mohamed; Raman, Nihal; Akarca, Fahire G; McCleary, Nadine J; Cleary, James M; Rubinson, Douglas A; Clark, Jeffrey W; Fitzpatrick, Bridget; Brais, Lauren K; Cavanaugh, Megan E; Rode, Amanda J; Jean, Melissa G; Lizotte, Patrick H; Nazzaro, Matthew J; Severgnini, Mariano; Zheng, Hui; Fuchs, Charles S; Enzinger, Peter C; Bass, Adam J